Search

Vimal K Kavuru

from Holmdel, NJ
Age ~56
Get Report
Also known as:
Vemal Kavuru, Vimal U
Phone and address:
11 Maacka Dr, Holmdel Village, NJ 07733
(732) 671-7195
Related to:
Raja S KavuruAudi Punati
Connected to:
Ayse Kavusturucu, 62Sedat Kavut, 63Dennis Kaw, 52Henry R Kaw, 49Hser N Kaw, 44Pooja P Kaw, 44Brian Kawa, 51Charles R Kawa, 107Graciela D Kawa, 83Hajimu A Kawa, 69

Vimal Kavuru Phones & Addresses

  • 11 Maacka Dr, Holmdel, NJ 07733 (732) 671-7195
  • 17 Lexington Ct, Holmdel, NJ 07733
  • Rumson, NJ
  • East Brunswick, NJ
  • Carlstadt, NJ
  • 26316 74Th Ave, Glen Oaks, NY 11004
  • 26316 74Th Ave APT C3, Glen Oaks, NY 11004
  • Manchester, CT
  • Elkins Park, PA
  • 11 Maacka Dr, Holmdel, NJ 07733

Resumes

Resumes

Vimal Kavuru Photo 1

Co-Founder And Chairman

View page
Location:
858 Navesink River Rd, Rumson, NJ 07760
Industry:
Pharmaceuticals
Work:
Aceto Corporation
Member Board of Directors
Rising Pharmaceuticals, Inc.
Executive Committee Member
Citron Pharma Jan 2013 - Dec 2016
Chief Executive Officer
Grace Therapeutics Jan 2013 - Dec 2016
Co-Founder and Chairman
Gensource Rx Apr 2008 - Jan 2013
Chief Executive Officer
Education:
Long Island University 1989 - 1992
Masters, Pharmacy Hkes College of Pharmacy 1985 - 1989
Bachelors, Bachelor of Science, Pharmacy College of Pharmacy 1985 - 1989
Bachelors, Bachelor of Science, Pharmacy *College of Pharmacy, Gulbarga, India 1985 - 1989
Bachelors, Bachelor of Science, Pharmacy Little Flower Degree College 1983 - 1985
University of Hyderabad
Skills:
Pharmaceutical Industry
Oncology
Managed Care
Pharmaceutical Sales
Pharmaceutics
Regulatory Affairs
Pharmacy
Healthcare
Product Launch
Business Development
Strategic Planning
Sales Effectiveness
Formulation
Marketing
Biotechnology
Clinical Trials
Market Access
Diabetes
Medical Devices
Cardiology
Lifesciences
Vimal Kavuru Photo 2

Vimal Kavuru

View page

Business Records

Name / Title
Company / Classification
Phones & Addresses
Vimal Kavuru
Managing
Cedardale Distributors, LLC
Distribution Company · Out of State Wholesaler of Pharmaceutica · Whol Drugs/Sundries
620 Gotham Pkwy, Carlstadt, NJ 07072
(201) 804-0800
Vimal Kavuru
CRONUS PHARMA, LLC
Whol Drugs/Sundries
2 Tower Ctr Blvd SUITE 1101A, East Brunswick, NJ 08816
Vimal Kavuru
Chief Executive Officer
CITRON PHARMA LLC
201 · Whol Drugs/Sundries
2 Tower Ctr Blvd SUITE 1101, East Brunswick, NJ 08816
620 Gotham Pkwy, Carlstadt, NJ 07072

Publications

Us Patents

Therapeutic Composition Of Intranasal Lidocaine

View page
US Patent:
20200197338, Jun 25, 2020
Filed:
Dec 4, 2019
Appl. No.:
16/703444
Inventors:
- East Brunswick NJ, US
Amresh Kumar - Plainsboro NJ, US
Prasanna Sunthankar - West Windsor NJ, US
Vimal Kavuru - Holmdel NJ, US
Kamalkishore Pati - Old Bridge NJ, US
Assignee:
Nortic Holdings Inc. - East Brunswick NJ
International Classification:
A61K 31/167
A61K 9/00
A61M 11/00
Abstract:
A nasal spray formulation and a method of using a locally acting sodium channel blocker to treat pain is disclosed, wherein the nasal spray formulation comprises from about 5% to about 30% w/v of a locally active sodium channel blocker, from about 0.25% to about 5% w/v of a buffering agent, and from about 5 to about 99% w/v of a pharmaceutically acceptable carrier for nasal administration. The nasal spray formulation is preferably contained in a mechanical multi-dose pump which sprays a unit dose of the nasal spray formulation with a wide plume and small droplet size, such that the unit dose is administered by actuating the mechanical multi-dose spray pump device and spraying a volume of the nasal spray formulation into each nostril of a human subject. Preferably, the nasal spray formulation does not include a preservative.

Methods Of Treatment Using Nimodipine Parenteral Formulations

View page
US Patent:
20200163947, May 28, 2020
Filed:
Oct 31, 2019
Appl. No.:
16/670163
Inventors:
- East Brunswick NJ, US
Amresh Kumar - Plainsboro NJ, US
Prasanna Sunthankar - West Windsor NJ, US
Vimal Kavuru - Holmdel NJ, US
Kamalkishore Pati - Old Bridge NJ, US
Assignee:
Nortic Holdings Inc. - East Brunswick NJ
International Classification:
A61K 31/4422
A61K 9/00
A61K 9/107
A61K 47/10
A61K 47/34
Abstract:
A method of treating a human patient suffering from subarachnoid hemorrhage (SAH), intra-cerebral hemorrhage, and traumatic brain injuries (TBI), and the like, comprising administering a nimodipine formulation suitable for parenteral injection, e.g., either via the subcutaneous or intramuscular route, is disclosed.

Stable Nimodipine Parenteral Formulation

View page
US Patent:
20190255033, Aug 22, 2019
Filed:
Feb 21, 2019
Appl. No.:
16/281676
Inventors:
- East Brunswick NJ, US
Amresh Kumar - Painsboro NJ, US
Prasanna Sunthankar - West Windsor NJ, US
Vimal Kavuru - Holmdel NJ, US
Kamalkishore Pati - Old Bridge NJ, US
Assignee:
NORTIC HOLDINGS INC. - East Brunswick NJ
International Classification:
A61K 31/451
A61K 9/00
A61K 47/26
A61K 47/10
A61P 9/04
A61P 9/06
A61P 9/10
A61P 9/12
A61P 9/14
Abstract:
A nimodipine injection concentrate and diluted formulation comprises nimodipine (base or salt), an effective amount of a hydrophilic surfactant, and a pharmaceutically acceptable carrier for injection which is an aqueous solution substantially free of organic solvent, such that the nimodipine is substantially contained in a concentrated injection solution, suspension, emulsion or complex as a micelle or a colloidal particle or an inclusion complex and the formulation is stable and clear. In certain embodiments, the hydrophilic surfactant is polysorbate 80.

Stable Nimodipine Parenteral Formulation

View page
US Patent:
20180325882, Nov 15, 2018
Filed:
Jul 26, 2018
Appl. No.:
16/046487
Inventors:
- East Brunswick NJ, US
Amresh Kumar - Plainsboro NJ, US
Prasanna Sunthankar - West Windsor NJ, US
Vimal Kavuru - Holmdel NJ, US
Kamalkishore Pati - Old Bridge NJ, US
Assignee:
NORTIC HOLDINGS INC. - East Brunswick NJ
International Classification:
A61K 31/4418
A61K 31/4422
A61K 47/44
A61K 47/24
A61K 47/26
A61K 9/107
A61K 9/00
A61K 47/10
Abstract:
A nimodipine injection concentrate and diluted formulation comprises nimodipine (base or salt), an effective amount of a hydrophilic surfactant, and a pharmaceutically acceptable carrier for injection which is an aqueous solution, an organic solvent, an oil, or a cyclodextrin, such that the nimodipine is substantially contained in a concentrated injection solution, suspension, emulsion or complex as a micelle or a colloidal particle or an inclusion complex and the formulation is stable and clear. In certain embodiments, the hydrophilic surfactant is polysorbate 80.

Stable Nimodipine Parenteral Formulation

View page
US Patent:
20180325886, Nov 15, 2018
Filed:
Jul 26, 2018
Appl. No.:
16/046476
Inventors:
- East Brunswick NJ, US
Amresh Kumar - Plainsboro NJ, US
Prasanna Sunthankar - West Windsor NJ, US
Vimal Kavuru - Holmdel NJ, US
Assignee:
NORTIC HOLDINGS INC. - East Brunswick NJ
International Classification:
A61K 31/455
A61K 31/4422
A61K 47/44
A61K 47/24
A61K 47/10
A61K 9/107
A61K 9/00
A61K 47/26
Abstract:
A nimodipine injection concentrate and diluted formulation comprises nimodipine (base or salt), an effective amount of a hydrophilic surfactant, and a pharmaceutically acceptable carrier for injection which is an aqueous solution, an organic solvent, an oil, or a cyclodextrin, such that the nimodipine is substantially contained in a concentrated injection solution, suspension, emulsion or complex as a micelle or a colloidal particle or an inclusion complex and the formulation is stable and clear. In certain embodiments, the hydrophilic surfactant is polysorbate 80.

Topical Film-Forming Spray

View page
US Patent:
20170296484, Oct 19, 2017
Filed:
Nov 23, 2016
Appl. No.:
15/360644
Inventors:
- New Brunswick NJ, US
Amresh Kumar - Plainsboro NJ, US
Prasanna Sunthankar - West Windsor NJ, US
Vimal Kavuru - Holmdel NJ, US
Assignee:
GRACE THERAPEUTICS LLC - New Brunswick NJ
International Classification:
A61K 9/70
A61K 47/32
A61K 47/22
A61K 31/7048
A61K 31/566
A61K 9/00
A61K 31/4468
A61K 31/445
A61K 31/167
A61K 31/135
A61K 47/34
A61K 31/568
Abstract:
A polymeric bio-adhesive film forming topical spray formulation providing a modified, pulsatile (e.g., biphasic) release of the active agent(s) once the solvent evaporates and the film sets, e.g., on human skin is disclosed. In certain embodiments, the active agent is bupivacaine hydrochloride.

Topical Film-Forming Spray

View page
US Patent:
20170296485, Oct 19, 2017
Filed:
Nov 23, 2016
Appl. No.:
15/360676
Inventors:
- New Brunswick NJ, US
Amresh Kumar - Plainsboro NJ, US
Prasanna Sunthankar - West Windsor NJ, US
Vimal Kavuru - Holmdel NJ, US
Assignee:
GRACE THERAPEUTICS LLC - New Brunswick NJ
International Classification:
A61K 9/70
A61K 9/00
A61K 31/445
A61K 45/06
Abstract:
A polymeric bio-adhesive film forming topical spray formulation providing a modified, pulsatile (e.g., biphasic) release of the active agent(s) once the solvent evaporates and the film sets, e.g., on human skin is disclosed. In certain embodiments, the active agent is bupivacaine hydrochloride.

Stable Nimodipine Parenteral Formulation

View page
US Patent:
20170296522, Oct 19, 2017
Filed:
Jun 30, 2017
Appl. No.:
15/638901
Inventors:
- New Brunswick NJ, US
Amresh Kumar - Plainsboro NJ, US
Prasanna Sunthankar - West Windsor NJ, US
Vimal Kavuru - Holmdel NJ, US
Kamalkishore Pati - Old Bridge NJ, US
Assignee:
GRACE THERAPEUTICS LLC - New Brunswick NJ
International Classification:
A61K 31/4418
A61K 47/02
A61K 9/00
A61K 9/107
A61K 47/26
A61K 47/10
Abstract:
A nimodipine injection concentrate and diluted formulation comprises nimodipine (base or salt), an effective amount of a hydrophilic surfactant, and a pharmaceutically acceptable carrier for injection which is an aqueous solution, an organic solvent, an oil, or a cyclodextrin, such that the nimodipine is substantially contained in a concentrated injection solution, suspension, emulsion or complex as a micelle or a colloidal particle or an inclusion complex and the formulation is stable and clear. In certain embodiments, the hydrophilic surfactant is polysorbate 80.
Control profile
Vimal K Kavuru from Holmdel, NJ, age ~56 Get Report